Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies

TOP News

Vialek Book Banner

PureTech Health entered into a multiyear collaboration with Roche

microscope
PureTech Health, a clinical-stage biopharmaceutical company developing novel medicines focused on the Brain-Immune-Gut (BIG) Axis, announced that it has entered into a multiyear collaboration with Roche.

Yisheng Biopharma sets up new divisions in Southeast Asia

drug-development
Yisheng Biopharma, a biopharmaceutical company focusing on research, development, manufacturing of immunological biologics and vaccines, announced the opening of two wholly owned subsidiaries in Cambodia.

Avalon GloboCare formed Avactis Biosciences to develop CAR-T therapies

research
Avalon GloboCare (USA), a leading global developer of cell-based technologies and therapeutics, formed a new wholly owned. subsidiary, Avactis Biosciences.

EU and Japan strenghten collaboration on inspections of drug manufacturers

drugs
The European Union (EU) and Japan have agreed to broaden the range of medicines for which they will recognise each other’s inspections of manufacturing sites.

British Parliament voted to keep UK in EMA after Brexit

uk-eu
On July 17, The UK Parliament voted 305-301 in favor of continuing the UK’s involvement with the European Medicines Agency (EMA) after the island leaves the EU.

Moderna Therapeutics launches new manufacturing facility

dna
Moderna Therapeutics, a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced the opening of its manufacturing facility in Norwood, Massachusetts (USA).

Sobi gained global rights for emapalumab from Novimmune

lab research
Swedish Orphan Biovitrum AB and Novimmune SA have entered into an licence agreement for the global rights to an orphan drug candidate for the treatment of primary Haemophagocytic lymphohistiocytosis (HLH).

Subscribe to GMP news Newsletter!

Interview

Counterfeit products will even not get into the licensed pharmacy chains

murashko
Russian State Duma adopted a bill on labeling of medicinal products with Data Matrix labels. This procedure will become mandatory from January 1, 2020

National producers entered the market with nearly a dozen of biosimilars

Denis Manturov
Denis Manturov told the correspondent of "Expert" magazine how the Ministry for Industry & Trade continues to work towards technical upgrading of the Russian industry, about current progress in th...

The long and expensive process to enter the international market

Nikolai Yemelianov - Niarmedic Plus
What is the difference between the native antiviral drugs and imported ones and what is necessary for their entry into foreign markets, described the head of the Department of medical research and inf...

Subscribe to GMP news Newsletter!

Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies